Functional MRI (fMRI) may be the key to identifying specific neurons in the brain that are central to distinguishing bipolar disorder from depression, reported researchers in a recent Biological Psychiatry: Cognitive Neuroscience and Neuroimaging study.

Patients with psychosis may benefit from therapeutic effects found to be derived from cannabidiol (CBD), a naturally occurring constituent of cannabis, according to research published Aug. 29 in JAMA Psychiatry.

The NYU School of Medicine’s department of radiology and Facebook recently announced a new collaborative research project focused on using artificial intelligence (AI) to make MRI scans up to 10 times faster.

Extramural venous invasion (EMVI) can be reliably evaluated with MRI in patients with locally advanced rectal cancer treated with neoadjuvant chemotherapy–radiation therapy followed by surgery, according to new research published in Radiology.

Researchers have developed a compact imaging system capable of capturing 5D images, sharing their findings in a new study published in Optics Express.

Brain MRIs have revealed that the anti-inflammatory drug ibudilast may slow down atrophy in patients with progressive multiple sclerosis (MS), according to research published Aug. 30 in the New England Journal of Medicine.

Cannabidiol (CBD), a major constituent of cannabis, has been found to have a therapeutic effect on patients with psychosis. That therapeutic effect may be a result of how CBD partially normalizes alterations found in the brains of patients at a high risk of psychosis, according to new fMRI research published in JAMA Psychiatry.

The National Institute for Mental Health (NIMH) has granted two Pittsburgh-based researchers a five-year, $3.8 million grant to better identify and treat individuals with suicidal thoughts using functional MRI (fMRI).